A detailed history of Plato Investment Management LTD transactions in Amgen Inc stock. As of the latest transaction made, Plato Investment Management LTD holds 18,708 shares of AMGN stock, worth $4.93 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
18,708
Previous 17,973 4.09%
Holding current value
$4.93 Million
Previous $5.62 Billion 7.23%
% of portfolio
0.49%
Previous 0.52%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$309.38 - $337.38 $227,394 - $247,974
735 Added 4.09%
18,708 $6.02 Billion
Q2 2024

Aug 08, 2024

BUY
$262.75 - $319.31 $232,533 - $282,589
885 Added 5.18%
17,973 $5.62 Billion
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $3.72 Million - $4.49 Million
13,845 Added 426.92%
17,088 $7.45 Billion
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $829,235 - $935,475
3,243 New
3,243 $934 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Plato Investment Management LTD Portfolio

Follow Plato Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plato Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Plato Investment Management LTD with notifications on news.